| Don G Laplant, MD | |
|
10452 Silverdale Way Nw, Silverdale, WA 98383-9460 | |
| (360) 307-7300 | |
| Not Available |
| Full Name | Don G Laplant |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 10452 Silverdale Way Nw, Silverdale, Washington |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073665287 | NPI | - | NPPES |
| 8124596 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD00024331 (Washington) | Primary |
| Entity Name | Kaiser Foundation Health Plan Of Washington |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396810701 PECOS PAC ID: 9032022579 Enrollment ID: O20031112000454 |
News Archive
The effect of a high-fat meal on blood vessel walls can vary among individuals depending on factors such as their waist size and triglyceride levels, suggests new research at UC Davis.
Scientists, health officials, and manufacturers already know that a chemical preservative found in some products, including cosmetics, is harmful to people and animals in high concentrations, but a new Brown University study in tadpoles reports that it can also interrupt neurological development even in very low concentrations.
According to new research that will be presented on Saturday, June 5, at the 19th Annual Meeting of the American Academy of Dental Sleep Medicine, an estimated 18 percent of pediatric patients in a University of North Carolina-based study were at-risk for sleep-related breathing disorders (SRBD). Importantly, pediatric risk was not associated with any demographic or craniofacial characteristics, as it is in adults, making it difficult to detect.
Researchers at The University of Texas M. D. Anderson Cancer Center and The University of Texas Health Science Center at Houston have found that human fat cells produce a protein that is linked to both inflammation and an increased risk of heart disease and stroke.
RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using immunotherapy and RNA-targeted technologies, today announced that it has priced an underwritten public offering of 11,950,000 units at a price to the public of $1.00 per unit for gross proceeds of approximately $12 million.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Don G Laplant, MD 10452 Silverdale Way Nw, Silverdale, WA 98383-9460 Ph: (360) 307-7300 | Don G Laplant, MD 10452 Silverdale Way Nw, Silverdale, WA 98383-9460 Ph: (360) 307-7300 |
News Archive
The effect of a high-fat meal on blood vessel walls can vary among individuals depending on factors such as their waist size and triglyceride levels, suggests new research at UC Davis.
Scientists, health officials, and manufacturers already know that a chemical preservative found in some products, including cosmetics, is harmful to people and animals in high concentrations, but a new Brown University study in tadpoles reports that it can also interrupt neurological development even in very low concentrations.
According to new research that will be presented on Saturday, June 5, at the 19th Annual Meeting of the American Academy of Dental Sleep Medicine, an estimated 18 percent of pediatric patients in a University of North Carolina-based study were at-risk for sleep-related breathing disorders (SRBD). Importantly, pediatric risk was not associated with any demographic or craniofacial characteristics, as it is in adults, making it difficult to detect.
Researchers at The University of Texas M. D. Anderson Cancer Center and The University of Texas Health Science Center at Houston have found that human fat cells produce a protein that is linked to both inflammation and an increased risk of heart disease and stroke.
RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using immunotherapy and RNA-targeted technologies, today announced that it has priced an underwritten public offering of 11,950,000 units at a price to the public of $1.00 per unit for gross proceeds of approximately $12 million.
› Verified 1 days ago
Sarah Elizabeth Plyler, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: Navy Medicine Readiness And Training Unit Bangor, 2050 Barb St, Silverdale, WA 98315 Phone: 360-315-4346 | |
Brian K Miller, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 10452 Silverdale Way Nw, Silverdale, WA 98383 Phone: 360-307-7300 Fax: 360-307-7510 | |
Saurav Poudyal, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1800 Nw Myhre Rd, Silverdale, WA 98383 Phone: 564-240-3120 | |
Lee W. Chu, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 10452 Silverdale Way Nw, Silverdale, WA 98383 Phone: 360-307-7300 | |
David Franklin Hogness, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 10452 Silverdale Way Nw, Silverdale, WA 98383 Phone: 360-307-7300 | |
Vanathi Siddaiah, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 10452 Silverdale Way Nw, Silverdale, WA 98383 Phone: 360-307-7300 |